Truist Financial reissued their buy rating on shares of PACS Group (NYSE:PACS – Free Report) in a research note released on Thursday,Benzinga reports. The brokerage currently has a $65.00 price target on the stock, up from their previous price target of $62.00.
Several other research firms have also weighed in on PACS. Wall Street Zen lowered PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Weiss Ratings raised PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Royal Bank Of Canada raised their target price on PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research report on Thursday, August 6th. Stephens lifted their target price on shares of PACS Group from $60.00 to $64.00 and gave the company an “overweight” rating in a research note on Thursday. Finally, JPMorgan Chase & Co. raised their price objective on shares of PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research report on Friday, September 4th. Six research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $61.33.
Check Out Our Latest Research Report on PACS
PACS Group Stock Down 0.5%
PACS stock opened at $50.03 on Thursday. PACS Group has a 52-week low of $10.31 and a 52-week high of $51.68. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.80 and a quick ratio of 0.91. The firm has a market capitalization of $7.94 billion, a P/E ratio of 28.26, a P/E/G ratio of 1.57 and a beta of -0.14. The company’s 50 day simple moving average is $44.53 and its 200-day simple moving average is $39.96.
PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.46 billion. PACS Group had a return on equity of 31.98% and a net margin of 4.87%. As a group, equities research analysts anticipate that PACS Group will post 2.13 EPS for the current year.
Insiders Place Their Bets
In other news, Director Mark Hancock sold 186,696 shares of the company’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $50.45, for a total transaction of $9,418,813.20. Following the completion of the transaction, the director directly owned 53,318,884 shares of the company’s stock, valued at $2,689,937,697.80. This represents a 0.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Michelle Lewis sold 3,172 shares of the firm’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $50.06, for a total transaction of $158,790.32. Following the transaction, the chief accounting officer directly owned 340,338 shares of the company’s stock, valued at $17,037,320.28. This represents a 0.92% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,762,431 shares of company stock worth $80,686,053 over the last ninety days. 70.10% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On PACS Group
Several large investors have recently made changes to their positions in PACS. Financial Management Professionals Inc. boosted its position in PACS Group by 54.9% during the second quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after purchasing an additional 235 shares during the period. GK Wealth Management LLC acquired a new stake in shares of PACS Group in the third quarter valued at approximately $41,000. USA Financial Formulas bought a new stake in shares of PACS Group during the 3rd quarter valued at $46,000. KBC Group NV acquired a new stake in PACS Group during the first quarter worth about $42,000. Finally, Western Wealth Management LLC bought a new position in shares of PACS Group in the 1st quarter valued at $48,000.
PACS Group News Roundup
Here are the key news stories impacting PACS Group this week:
- Positive Sentiment: Third-quarter EPS of $0.63 topped estimates of $0.58, while revenue of $1.50 billion exceeded the $1.46 billion consensus. Adjusted EBITDA reportedly rose 33.6%, reinforcing evidence of operating growth. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 2026: EBITDA Surges 33.6%
- Positive Sentiment: PACS raised its 2026 revenue outlook to $5.95 billion–$6.05 billion and adjusted EBITDA guidance to $685 million–$695 million. The company also highlighted acquisitions in Florida and Texas and facility occupancy around 90%, supporting its expansion story. PACS raises 2026 outlook PACS acquisitions and Q3 results
- Positive Sentiment: Truist reaffirmed its Buy rating and raised its target to $65 from $62; Stephens raised its target to $64 from $60 and assigned an Overweight rating. Higher targets signal continued analyst confidence in potential upside. Truist analyst ratings Stephens analyst ratings
- Negative Sentiment: The CEO, a director, and the chief accounting officer reported share sales. These could weigh slightly on sentiment, but the trades were made under pre-arranged Rule 10b5-1 plans, and the CEO and director retained large holdings. PACS insider transactions
About PACS Group
PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.
The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.
Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.
Further Reading
- Five stocks we like better than PACS Group
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
